The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Tumor-Specific CD4+ T Cells Have a Major “Post-Licensing” Role in CTL Mediated Anti-Tumor Immunity
Open accessAbstract
A number of tumor studies have indicated a link between CD4 help and the magnitude and persistence of CTL activity; however, the mechanisms underlying this have been largely unclear. To evaluate and determine the mechanisms by which CD4+ T cells synergize with CD8+ T cells to prevent tumor growth, we used the novel technique of monitoring in vivo CTL by labeling target cells with CFSE. This approach was supported by the direct visualization of CTL using peptide-MHC tetramers to follow tumor-specific T cells. The data presented demonstrate that while cotransfer of Ag-specific CD4+ T cells was not required for the generation of CTLs, because adoptive transfer of CD8+ T cells alone was sufficient, CD4+ T cells were required for the maintenance of CD8+ T cell numbers. Our data suggest that there is a correlation among the number of CD8+ T cells, in vivo CTL function, and IFN-γ production, with no evidence of a partial or nonresponsive phenotype among tetramer-positive cells. We also show that CD4+ T cells are required for CD8+ T cell infiltration of the tumor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Enhancement of Antitumor Immunity by CTLA-4 Blockade
Leach, D. R., Krummel, M. F., & Allison, J. P. (1996) · Science · doi:10.1126/science.271.5256.1734 · Cited by 3,955
T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions
Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R., & Melief, C. J. M. (1998) · Nature · doi:10.1038/31002 · Cited by 2,615
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
Ridge, J. P., Di Rosa, F., & Matzinger, P. (1998) · Nature · doi:10.1038/30989 · Cited by 2,342
Help for cytotoxic-T-cell responses is mediated by CD40 signalling
Bennett, S. R. M., Carbone, F. R., Karamalis, F., Flavell, R. A., Miller, J. F. A. P., & Heath, W. R. (1998) · Nature · doi:10.1038/30996 · Cited by 2,092
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978
Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,943
The Central Role of CD4+ T Cells in the Antitumor Immune Response
Hung, K., Hayashi, R., Lafond-Walker, A., Lowenstein, C., Pardoll, D., & Levitsky, H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2357 · Cited by 1,345
CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection
Matloubian, M., Concepcion, R. J., & Ahmed, R. (1994) · Journal of Virology · doi:10.1128/jvi.68.12.8056-8063.1994 · Cited by 1,157
LIGAND RECOGNITION BY αβ T CELL RECEPTORS
Davis, M. M., Boniface, J. J., Reich, Z., Lyons, D., Hampl, J., Arden, B., & Chien, Y.-H. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.523 · Cited by 924
Fearon, E. R., Pardoll, D. M., Itaya, T., Golumbek, P., Levitsky, H. I., Simons, J. W., Karasuyama, H., Vogelstein, B., & Frost, P. (1990) · Cell · doi:10.1016/0092-8674(90)90591-2 · Cited by 916
Garboczi, D. N., Hung, D. T., & Wiley, D. C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3429 · Cited by 689
Rahemtulla, A., Fung-Leung, W. P., Schilham, M. W., Kündig, T. M., Sambhara, S. R., Narendran, A., Arabian, A., Wakeham, A., Paige, C. J., Zinkernagel, R. M., et al. (1991) · Nature · doi:10.1038/353180a0 · Cited by 684
Ossendorp, F., Mengedé, E., Camps, M., Filius, R., & Melief, C. J. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.5.693 · Cited by 610
Cardin, R. D., Brooks, J. W., Sarawar, S. R., & Doherty, P. C. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.863 · Cited by 501
Oehen, S., & Brduscha-Riem, K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.10.5338 · Cited by 365
Quantification of antigen specific CD8+ T cells using an ELISPOT assay
Miyahira, Y., Murata, K., Rodriguez, D., Rodriguez, J. R., Esteban, M., Rodrigues, M. M., & Zavala, F. (1995) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)00327-s · Cited by 359
A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity
Scott, B., Liblau, R., Degermann, S., Marconi, L. A., Ogata, L., Caton, A. J., McDevitt, H. O., & Lo, D. (1994) · Immunity · doi:10.1016/1074-7613(94)90011-6 · Cited by 338
Self-citationKurts, C., Carbone, F. R., Barnden, M., Blanas, E., Allison, J., Heath, W. R., & Miller, J. F. A. P. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.12.2057 · Cited by 317
Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A.
Cormier, J. N., Salgaller, M. L., Prevette, T., Barracchini, K. C., Rivoltini, L., Restifo, N. P., Rosenberg, S. A., & Marincola, F. M. (1997) · PubMed · Cited by 277
CD8(+) T cell-mediated spontaneous diabetes in neonatal mice
Morgan, D. J., Liblau, R., Scott, B., Fleck, S., McDevitt, H. O., Sarvetnick, N., Lo, D., & Sherman, L. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.3.978 · Cited by 267
Self-citationLo, D., Freedman, J., Hesse, S., Palmiter, R. D., Brinster, R. L., & Sherman, L. A. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220421 · Cited by 211
Salgaller, M. L., Marincola, F. M., Cormier, J. N., & Rosenberg, S. A. (1996) · PubMed · Cited by 208
Ahmed, R., Butler, L. D., & Bhatti, L. (1988) · Journal of Virology · doi:10.1128/jvi.62.6.2102-2106.1988 · Cited by 198
Wick, M., Dubey, P., Koeppen, H., Siegel, C. T., Fields, P. E., Chen, L., Bluestone, J. A., & Schreiber, H. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.229 · Cited by 195
Establishment of a murine model of malignant mesothelioma
Davis, M. R., Manning, L. S., Whitaker, D., Garlepp, M. J., & Robinson, B. W. S. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520609 · Cited by 186
Self-citationTumor Antigens are Constitutively Presented in the Draining Lymph Nodes
Marzo, A. L., Lake, R. A., Lo, D., Sherman, L., McWilliam, A., Nelson, D., Robinson, B. W. S., & Scott, B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.5838 · Cited by 166
Self-citationCTL access to tissue antigen is restricted in vivo.
Ando, K., Guidotti, L., Cerny, A., Ishikawa, T., & Chisari, F. (1994) · Journal of Immunology · doi:10.4049/jimmunol.153.2.482 · Cited by 133
Marzo, A. L., Lake, R., Robinson, B. W. S., & Scott, B. (1999) · PubMed · Cited by 122
Self-citationOnrust, S. V., Hartl, P. M., Rosen, S. D., & Hanahan, D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118406 · Cited by 99
McCoy, K. D., Hermans, I. F., Fraser, J., Gros, G. S. L., & Ronchese, F. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.7.1157 · Cited by 75
The role of CD4+ tumor-infiltrating lymphocytes in human solid tumors
Goedegebuure, P. S., & Eberlein, T. J. (1995) · Immunologic Research · doi:10.1007/bf02918172 · Cited by 57
Bielefeldt‐Ohmann, H., Fitzpatrick, D. R., Marzo, A. L., Jarnicki, A., Himbeck, R. P., Davis, M. R., Manning, L. S., & Robinson, B. W. S. (1994) · Cancer Immunology Immunotherapy · doi:10.1007/bf01534421 · Cited by 57
Self-citation
Cited by
Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
Blass, E., & Ott, P. A. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00460-2 · Cited by 1,042
Dendritic Cells and Cancer Immunity
Gardner, A., & Ruffell, B. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.09.006 · Cited by 907
MHC-II neoantigens shape tumour immunity and response to immunotherapy
Alspach, E., Lussier, D. M., Miceli, A. P., Kizhvatov, I., DuPage, M., Luoma, A. M., Meng, W., Lichti, C. F., Esaulova, E., Vomund, A. N., et al. (2019) · Nature · doi:10.1038/s41586-019-1671-8 · Cited by 846
Memory T Cell Subsets, Migration Patterns, and Tissue Residence
Mueller, S. N., Gebhardt, T., Carbone, F. R., & Heath, W. R. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095954 · Cited by 839
Antony, P. A., Piccirillo, C. A., Akpinarli, A., Finkelstein, S. E., Speiss, P. J., Surman, D. R., Palmer, D. C., Chan, C.-C., Klebanoff, C. A., Overwijk, W. W., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2591 · Cited by 760
Metadata
- Authors
- Marzo, A. L., Kinnear, B. F., Lake, R. A., Frelinger, J. J., Collins, E. J., Robinson, B. W. S., & Scott, B.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-12-01
- Volume
- 165
- Issue
- 11
- Pages
- 6047-6055
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1826114831
- Cited by
- 334
- References
- 32
- FWCI
- 5.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.